Emerging Insights into Wnt/β-catenin Signaling in Head and Neck Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Signaling Pathways

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a severe cancer with poor outcomes and limited treatments.
• The Wnt/β-catenin signaling pathway is increasingly recognized for its critical role in HNSCC development and progression.
• β-catenin is a key mediator, balancing cell adhesion and gene transcription, crucial for cancer cell stemness, proliferation, and mesenchymal traits.

Purpose of the Study:

• To elucidate the multifaceted roles of the Wnt/β-catenin pathway in HNSCC pathobiology.
• To explore the regulatory mechanisms and network interactions of Wnt/β-catenin signaling in HNSCC.
• To evaluate the therapeutic potential of targeting the Wnt/β-catenin pathway in HNSCC.

Main Methods:

• Genomic characterization of HNSCC to identify mutations in Wnt/β-catenin pathway regulators.
• Analysis of Wnt/β-catenin interactions with transcription factors, coactivators, and corepressors.
• Investigation of Wnt/β-catenin's influence on tumor microenvironment components like extracellular matrix and immune cells.

Main Results:

• While β-catenin mutations are rare in HNSCC, pathway dysregulation is common due to mutations in upstream regulators like NOTCH1, FAT1, and AJUBA.
• Wnt/β-catenin signaling impacts epigenetic and transcriptional landscapes, fostering cancer cell stemness and aggressive phenotypes.
• β-catenin activity extends beyond tumor cells, modulating the tumor microenvironment, including fibrosis and immune responses.

Conclusions:

• The Wnt/β-catenin pathway is a central driver of HNSCC, promoting tumor growth, stemness, and metastasis.
• Aberrant Wnt/β-catenin signaling, often due to upstream mutations, confers oncogenic properties in HNSCC.
• Targeting the Wnt/β-catenin pathway presents a viable and attractive therapeutic strategy for managing HNSCC.